PVG Asset Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

PVG Asset Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,530	Closed	-$698K	–	43
2022 Q4	$698K	Buy	+4,530	New	+$668K	3.09%	8
2019 Q1	–	Sell	-4,850	Closed	-$602K	–	68
2018 Q4	$602K	Sell	4,850 -25	-0.5%	-$3.42K	0.59%	44
2018 Q3	$772K	Buy	+4,875	New	+$738K	0.55%	49

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

PVG Asset Management's FBT Position: Q1 2023 in Review

PVG Asset Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2023, closing a stake of 4,530 shares — an estimated $698K sold.

PVG Asset Management first reported a position in FBT in Q3 2018 and held it in 3 quarters. The position peaked at $772K in Q3 2018. 245 funds tracked by Wall St. Rank hold FBT as of Q1 2023.

PVG Asset Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2023 after selling out during the quarter.
PVG Asset Management sold 4,530 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2023, an estimated $698K.
PVG Asset Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2018 and held it in 3 quarters.
PVG Asset Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $772K in Q3 2018.
245 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2023.

Based on PVG Asset Management's 13F filing for Q1 2023, filed 24 Jul 2023.